Literature DB >> 21370209

Thrombophilia and pre-eclampsia.

Moniek P M de Maat1, Christianne J M de Groot.   

Abstract

Pre-eclampsia (P-EC) poses an increased risk for fetal and maternal morbidity and sometimes even mortality. Several risk factors have been identified, among which an important extensively studied group is formed by the early recognizable genetic factors resulting in thrombophilia. The discussion is ongoing whether the associations found for thrombophilia are true and clinically relevant. In this review, we address the association between P-EC and thrombophilia, its concerns, and the necessity of screening after a pregnancy complicated by hypertension. © Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21370209     DOI: 10.1055/s-0030-1270335

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  4 in total

1.  Futility of testing for factor V Leiden.

Authors:  Emmanuel J Favaloro; David McDonald
Journal:  Blood Transfus       Date:  2012-07       Impact factor: 3.443

2.  Is there a link among thrombophilia factors and preeclampsia?

Authors:  Danyelle R A Rios; Patrícia Nessrala Alpoim; Lara Carvalho Godoi; Fernanda Santos Mendes; Bashir Lwaleed; Lirlândia P Sousa; Luiza O Perucci; Maria G Carvalho; Karina B G Borges; Luci M S Dusse
Journal:  J Thromb Thrombolysis       Date:  2017-11       Impact factor: 2.300

3.  The role of genetics in pre-eclampsia and potential pharmacogenomic interventions.

Authors:  Paula Juliet Williams; Linda Morgan
Journal:  Pharmgenomics Pers Med       Date:  2012-01-20

4.  Effects of glycol-split low molecular weight heparin on placental, endothelial, and anti-inflammatory pathways relevant to preeclampsia.

Authors:  Jovian M Wat; Krista Hawrylyshyn; Dora Baczyk; Iain R Greig; John C Kingdom
Journal:  Biol Reprod       Date:  2018-11-01       Impact factor: 4.285

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.